NMN (Nicotinamide Mononucleotide)
NAD+ PrecursorAlso known as: NMN · Beta-NMN · Nicotinamide mononucleotide
A precursor to NAD+, a coenzyme central to energy metabolism and cellular repair. Studied for longevity, metabolic health, and cognitive function. Evidence in humans is early-stage.
The bottom line
NMN reliably raises NAD+ levels in humans and has early, real signals — better sleep and walking speed in older adults, improved insulin sensitivity in one trial — which is more than most longevity supplements can show. But 'raises a biomarker' is not 'slows aging': there are no long-term human trials demonstrating it actually reduces disease or extends healthspan, and that gap is the whole ballgame. It's also adulteration-prone, so a third-party Certificate of Analysis matters (see the sourcing checklist). Avoid with a cancer history or in pregnancy, and note its U.S. regulatory status is unsettled.
Our plain-language reading of the expert claims and research on this page. Not medical advice.
How expert claims hold up
178 of 189 claims assessed125 of 178 assessed claims supported or partially supported by published research
Expert Consensus
Dose divergence: Experts recommend different amounts (250-1200milligrams, 250 to 1200milligrams, 500-1000milligrams, 500 to 1000milligrams, 500–1000milligrams, 500milligrams, 250–500milligrams, 1000milligrams). Check the Stack & Timing tab for study-backed dosing ranges.
Evidence Summary
NMN (Nicotinamide Mononucleotide) has accumulated a modest but growing body of human clinical evidence, primarily from short-term randomized controlled trials and supported by two meta-analyses. The overall picture suggests NMN can reliably raise blood NAD+ levels in humans, with some functional benefits emerging in specific populations — but the magnitude of real-world health benefits remains uncertain and the long-term data are essentially absent. Most claims about NMN's anti-aging potential still rest heavily on mechanistic rationale and animal studies rather than robust human outcome data.
Read full evidence summary →Top studies
The Effect of Nicotinamide Mononucleotide and Riboside on Skeletal Muscle Mass and Function: A Systematic Review and Meta-Analysis.
The Effect of Nicotinamide Mononucleotide and Riboside on Skeletal Muscle Mass and Function: A Systematic Review and Meta-Analysis.
Effects of Nicotinamide Mononucleotide on Glucose and Lipid Metabolism in Adults: A Systematic Review and Meta-analysis of Randomised Controlled Trials.
Effects of Nicotinamide Mononucleotide on Glucose and Lipid Metabolism in Adults: A Systematic Review and Meta-analysis of Randomised Controlled Trials.
Expert Mentions
All 189 mentions
“NAD+ has an energizing effect and taking it at night can disrupt sleep for some people.”
Taking NMN at night can disrupt sleep for some people due to its energizing effect.
None of the provided studies report key findings, populations, or limitations in their metadata, making direct comparison impossible. Notably, PMID 38789831 — an RCT on older adults — appears to have…
“On all three counts, NMN looks promising. That said, I want to be clear: this is not a proven anti-aging drug.”
NMN looks promising based on mechanistic plausibility, safety profile, and early human data, but it is not a proven anti-aging drug.
Gary Brecka's cautious, nuanced claim that NMN is promising but unproven as an anti-aging drug aligns well with the available evidence base. Multiple RCTs (PMIDs 36482258, 33888596, 36797393, 38789831…
Safety, interactions & who should avoid NMN (Nicotinamide Mononucleotide)
generally_recognized_safe
Short-term NMN supplementation in healthy adults appears to be well-tolerated with no serious adverse events reported across available RCTs, including a dedicated safety evaluation study. However, long-term safety data beyond several months are lacking, and caution is warranted before drawing conclusions about extended use.
Available RCT evidence suggests NMN is generally well-tolerated in healthy adults at doses up to 1200 mg/day over study durations, with no serious adverse events reported in safety-focused trials. Long-term safety data beyond 12 months in humans remains limited, and most studies are of moderate quality.
Who should avoid it
Individuals with active cancer or a history of hormone-sensitive cancers should exercise caution and consult a physician, as NAD+ elevation may theoretically support tumor cell survival. Pregnant or breastfeeding individuals should avoid use due to insufficient safety data. Those on complex medication regimens should seek medical advice before use.
Known interactions
- ·Potential interaction with chemotherapy or cancer treatments due to NAD+'s role in DNA repair and cell survival pathways — theoretical concern, not established in human trials
- ·May theoretically interact with medications affecting methylation pathways (e.g., methotrexate) given NMN's impact on NAD+ metabolism and methyl group utilization
Pregnancy & breastfeeding
Our sources specifically flag pregnancy or breastfeeding considerations for NMN (Nicotinamide Mononucleotide) — see the cautions above.
We don’t assign pregnancy-safety ratings. Many supplements lack adequate safety data in pregnancy and breastfeeding, and the absence of a warning here does not mean a supplement is safe to take. Don’t start, stop, or continue any supplement while pregnant or nursing without your OB-GYN or midwife.
Read: Supplements during pregnancy & breastfeeding →This is educational information only. Consult a healthcare provider before starting any supplement.
Stay on top of NMN (Nicotinamide Mononucleotide) research
One email a month when new research on NMN (Nicotinamide Mononucleotide) is published.
Double opt-in · unsubscribe anytime · not medical advice.
Sourcing matters for NMN (Nicotinamide Mononucleotide)
One of the most adulteration-prone categories — independent testing has found products far below label, some with little or no actual NMN. (Note: NMN’s U.S. regulatory status is unsettled.)
What to check before you buy
- ✓Third-party Certificate of Analysis showing % purity (≥ ~99% for NMN); NR ideally a tested branded form
- ✓Labeled dose backed by an independent assay, not just the brand’s claim
- ✓Stability / storage handled (sealed, cool; NMN degrades with heat and moisture)
- ✓No proprietary "longevity blend" obscuring the actual NMN / NR amount
This is about product quality — separate from the evidence grade above, which scores the research. Our sourcing standards →
No buy link — yet
We only link products that meet our sourcing standards — use the checklist above if you’re shopping on your own. We haven’t linked one for NMN (Nicotinamide Mononucleotide) yet. Our standards →
Key findings
- ·NMN supplementation consistently increases circulating NAD+ levels in human adults across multiple RCTs, confirming it is bioavailable and metabolically active.
- ·A double-blind RCT in older adults found NMN maintained walking speed and improved sleep quality, suggesting modest functional benefits in aging populations.
- ·An RCT in prediabetic women found NMN supplementation improved muscle insulin sensitivity, indicating a potentially relevant metabolic effect in at-risk groups.
Evidence gaps
- ·There are no long-term (multi-year) human trials assessing whether NMN supplementation produces meaningful reductions in age-related disease, mortality, or sustained functional decline — all current RCTs are short-term.
- ·Optimal dosing, timing, and which populations are most likely to benefit remain poorly defined; most trials tested different doses and populations, making direct comparisons difficult.
- ·The translational gap between compelling animal aging data and human outcomes has not been bridged — it is unknown whether the NAD+ increases observed in human blood translate into the tissue-level and cellular benefits seen in preclinical models.